Meeting
2020 Gastrointestinal Cancers Symposium
Evaluation of the ratio of plasma fibrinogen to platelet in resectable pancreatic cancer.
Authors
Yusuke Arakawa
Tokushima University, Tokushima, Japan
Yusuke Arakawa , Mitsuo Shimada , Yuji Morine , Satoru Imura , Tetsuya Ikemoto , Yu Saito , Shinichiro Yamada , Masato Yoshikawa , Katsuki Miyazaki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 756)
Abstract #
756
Poster Bd #
N1
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Association of neutrophil, platelet, and lymphocyte ratios with prognosis in metastatic pancreatic cancer.
First Author: Jessica Allen
Poster
2018 Genitourinary Cancers Symposium
The role of the blood platelet-lymphocyte ratio, neutrophil–lymphocyte ratio and platelets in prognosis of metastatic renal cell carcinoma (mRCC).
First Author: Joanna Huszno
Poster
2018 Gastrointestinal Cancers Symposium
Correlation of neutrophil lymphocyte ratio, platelet lymphocyte ratio and rate of change of CA 19.9 in predicting outcome for metastatic pancreatic cancer.
First Author: Andrew Peter Dean
Poster
2015 Gastrointestinal Cancers Symposium
Analysis of prognostic factors in advanced pancreatic cancer (APDAC) patients (pts) undergoing to first-line nab-paclitaxel (Nab-P) and gemcitabine (G) treatment.
First Author: Guido Giordano